AGP Picks
View all

Health Professional Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Professional Times.

Press releases published on May 12, 2026

CRB Project Honored as 2026 ISPE Facility of the Year Awards Winner
FLYTE ACTIVATES HIGH-FREQUENCY PREAKNESS FLIGHT PROGRAM, DEPLOYING FLEET TO SERVE STRONG NORTHEAST DEMAND
IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update
InVitria Presents New Data at ASGCT 2026 on Recombinant Human Serum Albumin for Higher Lentiviral Vector Titers and Improved Cell Therapy Manufacturing
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights
Cloudbreak Pharma to Present at the Stifel 2026 Virtual Ophthalmology Forum
Solésence Reports First Quarter 2026 Financial Results
Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027
Debra Hussain Joins Chiesi USA as Vice President and Business Unit Leader, U.S. CARE
Lyell Immunopharma Announces Participation in May Investor Conferences
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update
Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer
Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive
Brain Cancer Canada Awards $100,000 “The Emily McIntosh Brain Cancer Research Grant” to Advance Breakthrough Immunotherapy for Glioblastoma
MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026

Share this page:

Sign up for:

Health Professional Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.